CDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of insomnia drug Suvorexant Ruchika Sharma4 Oct 2025 2:03 PM ISTMumbai: Bajaj Healthcare Limited has announced that it has received a positive recommendation from the Subject Expert Committee (SEC) (Neurology...
Cough Syrup crisis: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma medicines Ruchika Sharma4 Oct 2025 1:01 PM ISTJaipur: In a swift and decisive move, the Rajasthan government has suspended the state's drug controller and ordered the cessation of...
AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours Ruchika Sharma4 Oct 2025 11:27 AM ISTBangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate...
Lupin unveils Liraglutide Injection in US for diabetes Ruchika Sharma4 Oct 2025 10:32 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen,...
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India Susmita Roy3 Oct 2025 8:36 PM ISTNew Delhi: The Subject Expert Committee functioning under the Central Drugs Standard Control Organization (CDSCO) has granted approval for additional...
Cough Syrup Row: Rajasthan Practitioners Shift to Levocloperastine, Ambroxol Amid Dextromethorphan Concerns Parthika Patel3 Oct 2025 8:02 PM ISTNew Delhi: Amid rising caution over the use of the widely prescribed cough suppressant dextromethorphan, medical practitioners and pharmacies in Sri...
Dummy Pharma Firms Under Probe for Rs 71 Crore Drug Scam in UP Parthika Patel3 Oct 2025 7:30 PM ISTAgra: A massive fake medicine racket running through dummy firms has come under the scanner in Uttar Pradesh, with the pharmaceutical department in...
Trump Warns Pharma Firms of 5-8% Extra Tariffs Ahead of October Drug Pricing Deadline Parthika Patel3 Oct 2025 7:23 PM ISTNew Delhi: US President Donald Trump has issued a stern warning to pharmaceutical companies, cautioning that an additional 5-8% tariff will be levied...
CDSCO Panel Directs Malik Lifesciences to Revise Phase III Trial Protocol for Tamsulosin, Dutasteride, Tadalafil FDC Parthika Patel3 Oct 2025 7:17 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Malik Lifesciences Pvt Ltd to...
Zydus Lifesciences Dr Sharvil Patel takes over as IPA President Ruchika Sharma3 Oct 2025 5:01 PM ISTMumbai: The Indian Pharmaceutical Alliance (IPA) has announced a leadership transition, with Dr Sharvil Patel, Managing Director of Zydus...
Bangalore-based Indegene acquires BioPharm from Omnicom Health Group Ruchika Sharma3 Oct 2025 4:36 PM ISTPrinceton: Indegene announced the strategic acquisition of BioPharm, a Pennsylvania-based specialized marketing services agency and part of...
Zydus's Sentynl Therapeutics pediatric Menkes disease drug flagged by USFDA Ruchika Sharma3 Oct 2025 3:30 PM ISTSolana Beach: Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd., has...
